Beyond LDL-C: Precision Approaches to Residual Risk With Drs. James Underberg and Martha Gulati
This activity is supported by independent educational grants from Arrowhead Pharmaceuticals, Inc.; Chiesi USA, Inc.; Cleerly Health; Esperion Therapeutics, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.



